Tag Archives: Sebia
Capillarys 3 DBS and Newborn screening awareness month
September is Newborn screening (NBS) awareness month. Did you know that Sebia offers the Capillarys [...]
Sep
The power of isoelectric focusing on the diagnosis of Multiple Sclerosis (MS) in Ireland
What is Multiple Sclerosis? Multiple Sclerosis (MS) is a degenerative disease of the Central Nervous [...]
Aug
Why choose the Sebia Free Light Chain (FLC) assay?
Why is FLC Measurement so important? Multiple Myeloma (MM) and other plasma disorders can be [...]
Jun
Webinar Immunotyping vs. Immunofixation
Want to move to a more automated approach to the detection of M-proteins and the [...]
Apr
Early detection of Multiple Myeloma: The importance of serum protein electrophoresis
What is Multiple Myeloma? Multiple myeloma, also known as myeloma or Kahler’s disease, is a [...]
Apr
SEBIA HYDRASHIFT 2/4 daratumumab test kit
Introducing the SEBIA HYDRASHIFT 2/4 daratumumab test kit which mitigates daratumumab interferences in multiple myeloma [...]
Aug
The difficulties and pitfalls on HbS diagnosis
Who: SEBIA speaker Dr. Wajcman What: Educational webinar on the difficulties and pitfalls of HbS [...]
Jan
Latest information on the new Capillarys 3 Automation solutions from Sebia.
CAPILLARYS 3 TERA MC (Maximum Capacity) is able to process either very high volumes of [...]
Mar
The impact of red blood cell lifespan on HbA1c measurement
An article written by Thomas P. Lohmann, who is the Director of Medical and Scientific [...]
Feb
New HbA1c Publication
The impact of red blood cell lifespan on HbA1c measurement by Lohmann T, MDMedical Laboratory [...]
Dec
HSE Project 13054
MSC are delighted to announce our continued success in the Irish Multiple Myeloma arena. We [...]
Nov
High Resolution HbA1c Separation using the Sebia CAPILLARYS 3 TERA
HbA1c is widely used for the management and diagnosis of diabetes mellitus (DM). Correlation between [...]
May
- 1
- 2